(Q80939332)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15517668%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

title

A comparison of extended-release oxybutynin and tolterodine for treatment of overactive bladder in women (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15517668%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

author name string

Peter K Sand

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15517668%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

John Miklos

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15517668%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Henry Ritter

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15517668%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Rodney Appell

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15517668%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

publication date

1 July 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15517668%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15517668%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15517668%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

243-248

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15517668%20AND%20SRC:MED&resulttype=core&format=json

Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladder

4 January 2020

cites work

1 reference

12 December 2020

The urinary diary in evaluation of incontinent women: a test-retest analysis

1 reference

12 December 2020

Evaluation of a new once-daily formulation of oxbutynin for the treatment of urinary urge incontinence. Ditropan XL Study Group

1 reference

12 December 2020

Economic costs of urinary incontinence in 1995.

1 reference

12 December 2020

Medical treatment of overactive bladder

1 reference

12 December 2020

Epidemiology and psychosocial aspects of incontinence

1 reference

12 December 2020

Once daily controlled versus immediate release oxybutynin chloride for urge urinary incontinence. OROS Oxybutynin Study Group

1 reference

12 December 2020

Oxybutynin. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability.

1 reference

12 December 2020

The association of depressive symptoms and urinary incontinence among older adults

1 reference

12 December 2020

Is the treatment of urgency incontinence a placebo response? Results of a five-year follow-up

1 reference

12 December 2020

Clinical efficacy and safety of tolterodine compared to placebo in detrusor overactivity

1 reference

12 December 2020

The influence of urinary incontinence on the quality of life of elderly women.

1 reference

12 December 2020

Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT Study.

1 reference

12 December 2020

Tolterodine once-daily: superior efficacy and tolerability in the treatment of the overactive bladder.

1 reference

12 December 2020

Clinical efficacy and safety of tolterodine in the treatment of overactive bladder: a pooled analysis

1 reference

12 December 2020

Prospective, randomized, double-blind study of the efficacy and tolerability of the extended-release formulations of oxybutynin and tolterodine for overactive bladder: results of the OPERA trial

1 reference

12 December 2020

Continence for women: evidence-based practice

1 reference

12 December 2020

Social context, social abstention, and problem recognition correlated with adult female urinary incontinence

1 reference

12 December 2020

Oxybutynin : A New Drug with Analgesic and Anticholinergic Properties

1 reference

12 December 2020

Dry mouth with conventional and controlled-release oxybutynin in urinary incontinence. The Ditropan XL Study Group

1 reference

12 December 2020

10.1007/S00192-004-1161-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15517668%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference